[PDF] Top 20 Empresas recuperadas por los trabajadores: una década de lucha por la dignidad en Argentina
Has 10000 "Empresas recuperadas por los trabajadores: una década de lucha por la dignidad en Argentina" found on our website. Below are the top 20 most common "Empresas recuperadas por los trabajadores: una década de lucha por la dignidad en Argentina".
Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
... A-induced liver injury (11), the suppressive effects of MSCs on production of TNF-α and IFN-γ, might explain the reduced apoptotic cell death in liver sinusoidal endothelial cells and hepatocytes, ... See full document
7
Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
... with liver cirrhosis and did not observe treatment ...against liver cirrhosis with a variety of etiologies, and improvement of liver function was ...alcoholic liver cirrhosis, and improvement ... See full document
8
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
... in cell- to-cell communication ...the stem cell phenotype. Areas of influence in- clude cell cycle passage, complex interactions with stro- mal cells, and MV-mediated ... See full document
9
A combination of ultrasound-targeted microbubble destruction with transplantation of bone marrow mesenchymal stem cells promotes recovery of acute liver injury
... that stem cells can be used as a hepatocyte regeneration source for repairing an injured liver [4, ...Of stem cells, bone marrow-derived mesenchymal stem cells (BMSCs) have demonstrated ... See full document
63
Progress in mesenchymal stem cell–based therapy for acute liver failure
... host liver and improve liver functions ...hematologic diseases [15], the side effects, including thrombocytopenia, myelosuppression, and pneumonia, are obvious ... See full document
15
Modulation of mesenchymal stem cell genotype and phenotype by extracellular matrix proteins
... the cell analysis. Equine liver was used as a positive control for anti-vinculin antibody binding (Kawai 2003) and the secondary antibody alone used as a negative control (for non-specific ... See full document
15
A pooled analysis of mesenchymal stem cell-based therapy for liver disease
... and cell-based therapies. Cell-based therapy using mesenchymal stem cells (MSCs) shows considerable promise ...multiple mesenchymal cell lineages, such as adipo- cytes and ... See full document
71
Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation
... protein dependent manner [32], and our findings fit into a general hypothe- sis of a HIV mediated disregulation of MSC ...MSC/OB cell types 'prime' these cells to the inhibitory effects of ...MSC/OB ... See full document
6
Mesenchymal stem cells in arthritic diseases
... hematopoietic stem cell transplantation after immune ablation treatment has become an ...is dependent on the proinflammatory cytokine TNF- α ... See full document
13
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
... vitro cell- free MSC-sourced secretome is economical and practical for clinical applications ...[26]. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, em- boli formation, ... See full document
13
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
... of diseases such as neural, heart, liver, intestinal, and lung ...T cell activation and expansion; induce regulatory T cells; alter the polarity of macrophages to the anti-inflammatory phenotype; and ... See full document
20
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
... the liver is a well- known cause of morbidity and mortality after OLT and ...with liver IRI by downregulating IL-6, IL-21, and CD70 and activating the neurogenic locus Notch homolog protein pathway; the ... See full document
14
Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis
... injured liver [14, 15], although this statement is contro- ...also mesenchymal cells simultaneously contribute to the initiation and development of liver diseases, although the mechanisms ... See full document
8
Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levels
... dose- dependent manner upon addition of TNF-α neutralising antibodies, thus confirming the role of TNF-α in inducing proliferation of ...of cell- to-cell contact in modulating the cell cycle ... See full document
20
An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells
... SK-MES-1 cell line and showed that centrifuge-based concentrating methods are more appropriate than pressure-driven concentrating devices and allow rapid isolation of ... See full document
16
Targeting subchondral bone mesenchymal stem cell activities for intrinsic joint repair in osteoarthritis
... bone-resident mesenchymal stem cells (MSCs) in these bone remodeling responses, and a proposal that targeting MSC activities in OA subchondral bone could represent a novel approach for intrinsic joint ... See full document
22
Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure
... Studies have reported that MSC transplantation does not trigger a host-versus-graft response because MSCs lack co-stimulatory molecules and human leukocyte antigen class II [12]. Therefore, MSCs are suitable for ... See full document
93
Current Status of Stem Cell Therapy for Thromboangiitis Obliterans (Buerger's Disease)
... Buerger's disease or Thromboangiitis Obliterans (TAO) is a nonatherosclerotic segmental vascular disease which affects small and medium arteries and veins in the upper and lower extremities. Based on pathological ... See full document
12
Mesenchymal stem cell infusion for the treatment of neurological sequelae of canine distemper virus: a clinical study
... Patient G showed the most clinical evolution of the parameters that were evaluated. On day 1, the patient was apathetic and lying on its side, with tetraparesis, though able to drag itself and change position. When ... See full document
13
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis
... into liver cells in the liver ...the liver and in the serum suggest the possibility of cell number expansion in the body after cell ...damaged liver, (4) MSCs change matrix ... See full document
56
Related subjects